-
www.cpsi.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
January 01, 2023 - Year-to-year colorectal cancer
screening was not assessed due to recent changes in how these data are
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-nhqdr-es-rev.pdf
January 01, 2023 - Year-to-year colorectal cancer
screening was not assessed due to recent changes in how these data are
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
January 01, 2023 - Receipt of Targeted Therapy and Survival
Outcomes in Patients With Metastatic Colorectal Cancer.
-
hcup-us.ahrq.gov/db/nation/nis/reports/2004niscomparisonrpt.jsp
May 01, 2016 - Hemodialysis
290 (9)
258 (15)
5.39 (0.06)
6.19 (0.54)
3.46 (0.10)
3.55 (0.30)
78: Colorectal … 1.15 (0.13)
1.16
5.71 (0.23)
5.51
5.39 (0.27)
5.34
$21,008 (1,444)
$20,647
78: Colorectal
-
hcup-us.ahrq.gov/reports/methods/2007_03.pdf
January 01, 2007 - 0.00)
58: Hemodialysis 290
(9)
258
(15)
5.39
(0.06)
6.19
(0.54)
3.46
(0.10)
3.55
(0.30)
78: Colorectal … 161
(18)
145 1.15
(0.13)
1.16 5.71
(0.23)
5.51 5.39
(0.27)
5.34 $21,008
(1,444)
$20,647
78: Colorectal
-
effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol
November 22, 2011 - : Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - Adherence to surveillance
care guidelines after breast and colorectal cancer treatment with curative
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_technical-brief.pdf
October 01, 2014 - Adherence to surveillance
care guidelines after breast and colorectal cancer treatment with curative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - A risk-profiling approach for surveillance of
inflammatory bowel disease-colorectal
carcinoma is more
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - A risk-profiling approach for surveillance of
inflammatory bowel disease-colorectal
carcinoma is more
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - Anti-epidermal
growth factor receptor treatment effect modification by KRAS mutations in advanced
colorectal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - Anti-epidermal
growth factor receptor treatment effect modification by KRAS mutations in advanced
colorectal
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - A risk-profiling approach for surveillance of
inflammatory bowel disease-colorectal
carcinoma is more
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
December 15, 2013 - The PLCO (Prostate, Lung, Colorectal, and Ovarian) Cancer Screening Trial reported no mortality benefit … Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer
-
effectivehealthcare-admin.ahrq.gov/products/decision-models-guidance/methods
April 01, 2021 - A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about … Bayesian calibration of a natural history model with application to a population model for colorectal … Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S.
-
patientregistry.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - Smoking
exposure as a risk factor for prevalent and
recurrent colorectal adenomas.
-
cahps.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - Smoking
exposure as a risk factor for prevalent and
recurrent colorectal adenomas.
-
pbrn.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - Smoking
exposure as a risk factor for prevalent and
recurrent colorectal adenomas.
-
pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - Smoking
exposure as a risk factor for prevalent and
recurrent colorectal adenomas.
-
healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/tobaccogenrefs.pdf
January 01, 2010 - Smoking
exposure as a risk factor for prevalent and
recurrent colorectal adenomas.